Chicago, IL – November 22, 2011 - Stocks in this week's article include Antares Pharma, Inc. (AMEX: , Global Cash Access Holdings, Inc. (NYSE: , InnerWorkings, Inc. (NASDAQ: (INWK - Free Report) , Raptor Pharmaceuticals Corp. (NASDAQ: and TASER International, Inc. (NASDAQ: . Kevin Matras departs from his typical stock screening to find stocks under $10 with explosive potential.
Screen of the Week written by Kevin Matras of Zacks Investment Research:
This screen is a bit of a departure from my normal stock screens. Usually I require my screens to have a minimum price of $10 per share. But I do at times scan for stocks under $10. And that's one of the screens I'm running for myself right now.
My minimum has typically been $10. With over 10,000 stocks out there, this minimum quickly lets me cull down several thousand stocks with a click of a button.
That doesn't mean there aren't any good stocks below that price point, because there are.
But, when screening for ideal stock candidates (and for me, a price under $10 is typically less than ideal), a $10 minimum does the trick.
But I can recall several sub-$10 stocks in the past that worked out exceptionally well. Maybe it's because I use them sparingly. Or maybe it's because I'm ultra picky in selecting them.
Either way, there can be a place for cheaper stocks in your portfolio sometimes.
And that's what we're looking at today...
For the rest of this Screen of the Week article, please visit Zacks.com at: https://www.zacks.com/commentary/19512/
Sign up now for your free trial today and start picking better stocks immediately. And with the backtesting feature, you can test your ideas to see how you can improve your trading in both up markets and down markets. Don't wait for the market to get better before you decide to do better. Start learning how to be a better trader today: https://at.zacks.com/?id=5529
Disclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material.
About Screen of the Week
Zacks.com created the first and best screening system on the web earning the distinction as the "#1 site for screening stocks" by Money Magazine. But powerful screening tools is just the start. That is why Zacks created the Screen of the Week to highlight profitable stock picking strategies that investors can actively use. Each week, Zacks Profit from the Pros free email newsletter shares a new screening strategy. Learn more about it here https://at.zacks.com/?id=5530
Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978 by Leonard Zacks. As a PhD in mathematics Len knew he could find patterns in stock market data that would lead to superior investment results. Amongst his many accomplishments was the formation of his proprietary stock picking system; the Zacks Rank, which continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit from the Pros https://at.zacks.com/?id=5531
Follow us on Twitter: http://twitter.com/zacksresearch
Join us on Facebook: http://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts
Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.
Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.
Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.
Contact: Jim Giaquinto